Forentis Fund

Speaking on biotech investing tomorrow at the World Precision Medicine Congress in London http://ow.ly/HqVr30bQob2 #WATRMC17

Advances in liquid biopsies are propelling precision medicine, lowering costs and saving lives...

Lipidomics is a new frontier in biomarker discovery according to this white paper.

Encouraging report for biotech startups...

Our group is developing assets for the liquid biopsy market - key to #precisionmedicine - bring on the #biomarkers!

Early cancer detection is critical and what we are all about. Check out this new post on MedDeviceOnline

New data suggests that epigenetic changes control how DNA operates to confer survival advantages on subsets of pancreatic cancer cells. "What we found astonished us," remarked co-senior study investigator Andrew Feinberg, M.D., professor of epigenetics at The Johns Hopkins University and a Johns Hopkins Kimmel Cancer Center member.

The Promise of Precision Medicine Fortunately, we can benefit from the current flood of genomic, transcriptomic, proteomic, and epigenomic data, which offers the potential to truly understand the mechanisms of individual response at the molecular level.

According to a report the precision medicine market will grow at a CAGR of 10.5% and reach $87 billion by 2023. http://ow.ly/Fh243081gth

Barcoding Cancer Drugs Researchers now have the ability to track drugs to cancer cells: "This technology provides a new window into fundamental insights about the mechanisms of cancer and resistance to various drugs."

Personalized Medicine Revolution in Glaucoma According to Dr. Robert Weinreb, new technologies will enable ophthalmologists to treat patients as individuals, with a course fo surgery or treatment tailored to their individual needs. He predicts a transformative and cataclysmic change.

A Precision Medicine Approach to Schizophrenia In the international literature schizophrenia is no longer regarded as a single illness, but as a group of separate conditions, some of which have yet to be defined. Psychiatrist Jan Dirk Blom asserts that a method of diagnosis and treatment that recognizes the individual with his or her unique combination of symptoms, characteristics, coping mechanisms and talents should be investigated.